Purchases and Sales Made in Q4 2023 in Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO) during Q4 2023. The information is specifically focused on institutions that hold shares of Xilio Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
189K+ 913.04% |
$94.5K - $473K
|
210K
$185K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
101K+ 384.54% |
$50.5K - $253K
|
127K
$112K
|
|
|
Feb 14, 2024
Q4 2023
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
BUY
|
- |
83.4KNew |
$41.7K - $208K
|
83.4K
$73.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
51.4KNew |
$25.7K - $129K
|
51.4K
$45.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
45K+ 40.73% |
$22.5K - $113K
|
155K
$137K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
17.5K+ 135.39% |
$8.73K - $43.6K
|
30.4K
$26.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
12.2K+ 1.37% |
$6.09K - $30.4K
|
903K
$794K
|
|
|
Feb 26, 2024
Q4 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
10.8KNew |
$5.38K - $26.9K
|
10.8K
$9.47K
|
|
|
Feb 12, 2024
Q4 2023
|
Dunhill Financial, LLC
London, X0 |
BUY
|
- |
10.3KNew |
$5.14K - $25.7K
|
10.3K
$9.04K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
10.1K+ 259.99% |
$5.05K - $25.2K
|
14K
$12.3K
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
135+ 4.96% |
$67.5 - $338
|
2.86K
$2.51K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
118+ 33.71% |
$59 - $295
|
468
$412
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
6+ 6.0% |
$3 - $15
|
106
$93.3
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-522- 1.1% |
$261 - $1.31K
|
46.9K
$41.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-26.1K- 18.23% |
$13K - $65.1K
|
117K
$103K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-227K- 100.0% |
$114K - $568K
|
11
$9.68
|
|
|
Feb 14, 2024
Q4 2023
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-640K- 26.39% |
$320K - $1.6M
|
1.79M
$1.57M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-985K- 88.56% |
$493K - $2.46M
|
127K
$112K
|